Prenatal exposure to antibodies from mothers of children with autism produces neurobehavioral alterations: A pregnant dam mouse model

Journal of Neuroimmunology

Volumn 211, Issue 1-2, 2009, Pages 39-48

  Singer, Harvey S ^a   Morris, Christina ^a   Gause, Colin ^a   Pollard, Matthew ^a   Zimmerman, Andrew W ^a,b   Pletnikov, Mikhail ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

Autism; Immune disorder; Neurobehavioral problems; Pregnant dam model; Transplacental antibodies

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; IMMUNOGLOBULIN G; INTERLEUKIN 12; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ACOUSTIC REFLEX; ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; AUDITORY STIMULATION; AUTISM; BEHAVIOR DISORDER; BRAIN TISSUE; CELL ACTIVATION; CHILD BEHAVIOR; CONTROLLED STUDY; CYTOKINE RELEASE; EMBRYO; FEMALE; GLIA CELL; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PILOT STUDY; PLACENTAL TRANSFER; PREGNANCY; PRENATAL EXPOSURE; PREPULSE INHIBITION; PRIORITY JOURNAL; SOCIAL INTERACTION; STARTLE REFLEX;

ADULT; ANIMALS; AUTISTIC DISORDER; BEHAVIOR, ANIMAL; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PSYCHOMOTOR DISORDERS;

EID: 67349116508     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.03.011     Document Type: Article

References (48)

1. Andres C. Molecular genetics and animal models in autistic disorder. Brain Res. Bull. 57 (2002) 109-119
2. Archelos J.J., and Hartung H.P. Pathogenetic role of autoantibodies in neurological diseases. Trends Neurosci. 23 (2000) 317-327
3. Ashdown H., Dumont Y., Ng M., Poole S., Boksa P., and Luheshi G.N. The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia. Mol. Psychiatry 11 (2006) 47-55
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV (1994), American Psychiatric Association, Washington, D.C.
5. Braunschweig D., Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Croen L.A., Pessah I.N., and Van de Water J. Autism: maternally derived antibodies specific for fetal brain proteins. Neurotoxicology 29 (2008) 226-231
6. Chen L., and Toth M. Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience 103 (2001) 1043-1050
7. Comi A.M., Zimmerman A.W., Frye V.H., Law P.A., and Peeden J.N. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J. Child Neurol. 14 (1999) 388-394
8. Connolly A.M., Chez M., Streif E.M., Keeling R.M., Golumbek P.T., Kwon J.M., Riviello J.J., Robinson R.G., Neuman R.J., and Deuel R.M. Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biol. Psychiatry 59 (2006) 354-363
9. Crawley J.N. Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res. 835 (1999) 18-26
10. Crawley J.N. Mouse behavioral assays relevant to the symptoms of autism. Brain Pathol. 17 (2007) 448-459
11. Croen L.A., Braunschweig D., Haapanen L., Yoshida C.K., Fireman B., Grether J.K., Kharrazi M., Hansen R.L., Ashwood P., and Van de Water J. Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study. Biol. Psychiatry 64 (2008) 583-588
12. Cruz A.P., Frei F., and Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol. Biochem. Behav. 49 (1994) 171-176
13. Dalton P., Deacon R., Blamire A., Pike M., McKinlay I., Stein J., Styles P., and Vincent A. Maternal neuronal antibodies associated with autism and a language disorder. Ann. Neurol. 53 (2003) 533-537
14. Dierssen M., Fotaki V., Martinez de Lagran M., Gratacos M., Arbones M., Fillat C., and Estivill X. Neurobehavioral development of two mouse lines commonly used in transgenic studies. Pharmacol. Biochem. Behav. 73 (2002) 19-25
15. Djalali S., Holtje M., Grosse G., Rothe T., Stroh T., Grosse J., Deng D.R., Hellweg R., Grantyn R., Hortnagl H., and Ahnert-Hilger G. Effects of brain-derived neurotrophic factor (BDNF) on glial cells and serotonergic neurones during development. J. Neurochem. 92 (2005) 616-627
16. Eikelis N., and Van Den Buuse M. Cardiovascular responses to open-field stress in rats: sex differences and effects of gonadal hormones. Stress 3 (2000) 319-334
17. Gayle D.A., Beloosesky R., Desai M., Amidi F., Nunez S.E., and Ross M.G. Maternal LPS induces cytokines in the amniotic fluid and corticotropin releasing hormone in the fetal rat brain. Am. J. Physiol., Regul. Integr. Comp. Physiol. 286 (2004) R1024-1029
18. Golan H.M., Lev V., Hallak M., Sorokin Y., and Huleihel M. Specific neurodevelopmental damage in mice offspring following maternal inflammation during pregnancy. Neuropharmacology 48 (2005) 903-917
19. Grider M.H., Mamounas L.A., Le W., and Shine H.D. In situ expression of brain-derived neurotrophic factor or neurotrophin-3 promotes sprouting of cortical serotonergic axons following a neurotoxic lesion. J. Neurosci. Res. 82 (2005) 404-412
20. Karl T., Pabst R., and von Horsten S. Behavioral phenotyping of mice in pharmacological and toxicological research. Exp. Toxicol. Pathol. 55 (2003) 69-83
21. Lang P.J., Bradley M., and Cuthbert B.N. Emotion, attention, and the startle reflex. Psychol. Rev. 97 (1990) 377-395
22. Locksley R.M., Killeen N., and Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104 (2001) 487-501
23. Lord C., Risi S., Lambrecht L., Cook E.H.J., Leventhal B.L., DiLavore P.C., Pickles A., and Rutter M. The autism diagnostic observation schedule - generic: a standard measure of social and communication deficits associated with the spectrum of autism. J. Autism Dev. Disord. 30 (2000) 205-223
24. Mamounas L.A., Blue M.E., Siuciak J.A., and Altar C.A. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J. Neurosci. 15 (1995) 7929-7939
25. Martin L.A., Ashwood P., Braunschweig D., Cabanlit M., Van de Water J., and Amaral D.G. Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain Behav. Immun. 22 (2008) 806-816
26. Meyer U., Nyffeler M., Engler A., Urwyler A., Schedlowski M., Knuesel I., Yee B.K., and Feldon J. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J. Neurosci. 26 (2006) 4752-4762
27. Moretti P., Bouwknecht J.A., Teague R., Paylor R., and Zoghbi H.Y. Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndrome. Hum. Mol. Genet. 14 (2005) 205-220
28. Moy S.S., Nadler J.J., Young N.B., Perez A., Holloway L.P., Barbaro R.P., Barbaro J.R., Wilson L.M., Threadgill D.W., Lauder J.M., Magnuson T.R., and Crawley J.N. Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav. Brain Res. 176 (2007) 4-20
29. Nelson K.B., Grether J.K., Croen L.A., Dambrosia J.M., Dickens B.F., Jelliffe L.L., Hansen R.L., and Phillips T.M. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann. Neurol. 49 (2001) 597-606
30. Ozawa K., Hashimoto K., Kishimoto T., Shimizu E., Ishikura H., and Iyo M. Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol. Psychiatry 59 (2006) 546-554
31. Perry E.K., Lee M.L., Martin-Ruiz C.M., Court J.A., Volsen S.G., Merrit J., Folly E., Iversen P.E., Bauman M.L., Perry R.H., and Wenk G.L. Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am. J. Psychiatry 158 (2001) 1058-1066
32. Plioplys A.V., Greaves A., and Yoshida W. Anti-CNS antibodies in childhood neurologic diseases. Neuropediatrics 20 (1989) 93-102
33. Ricceri L., Moles A., and Crawley J. Behavioral phenotyping of mouse models of neurodevelopmental disorders: relevant social behavior patterns across the life span. Behav. Brain Res. 176 (2007) 40-52
34. Schneider T., Roman A., Basta-Kaim A., Kubera M., Budziszewska B., Schneider K., and Przewlocki R. Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid. Psychoneuroendocrinology 33 (2008) 728-740
35. Schopler E., Reichler R.J., and Renner B.R. The childhood autism rating scale (CARS): for diagnostic screening and classification of autism (1986), Irvington, New York 63
36. Shi L., Fatemi S.H., Sidwell R.W., and Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J. Neurosci. 23 (2003) 297-302
37. Singer H.S., Morris C.M., Williams P.N., Yoon D.Y., Hong J.J., and Zimmerman A.W. Antibrain antibodies in children with autism and their unaffected siblings. J. Neuroimmunol. 178 (2006) 149-155
38. Singer H.S., Morris C.M., Gause C.D., Gillin P.K., Crawford S., and Zimmerman A.W. Antibodies against fetal brain in sera of mothers with autistic children. J. Neuroimmunol. 194 (2008) 165-172
39. Singh V.K., Warren R.P., Odell J.D., Warren W.L., and Cole P. Antibodies to myelin basic protein in children with autistic behavior. Brain Behav. Immun. 7 (1993) 97-103
40. Singh V.K., Warren R., Averett R., and Ghaziuddin M. Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr. Neurol. 17 (1997) 88-90
41. Smith S.E., Li J., Garbett K., Mirnics K., and Patterson P.H. Maternal immune activation alters fetal brain development through interleukin-6. J. Neurosci. 27 (2007) 10695-10702
42. Swerdlow N.R., Braff D.L., and Geyer M.A. Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav. Pharmacol. 11 (2000) 185-204
43. Todd R.D., and Ciaranello R.D. Demonstration of inter- and intraspecies differences in serotonin binding sites by antibodies from an autistic child. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 612-616
44. Treit D., and Fundytus M. Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol. Biochem. Behav. 31 (1988) 959-962
45. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev., Immunol. 3 (2003) 133-146
46. Vincent A., Deacon R., Dalton P., Salmond C., Blamire A.M., Pendlebury S., Johansen-Berg H., Rajogopalan B., Styles P., and Stein J. Maternal antibody-mediated dyslexia? Evidence for a pathogenic serum factor in a mother of two dyslexic children shown by transfer to mice using behavioural studies and magnetic resonance spectroscopy. J. Neuroimmunol. 130 (2002) 243-247
47. Vincent A., Dalton P., Clover L., Palace J., and Lang B. Antibodies to neuronal targets in neurological and psychiatric diseases. Ann. N. Y. Acad. Sci. 992 (2003) 48-55
48. Zimmermann C.W. Repertoires of natural autoantibodies against muscle tissue are independent of age or gender in normal human adults. A Western blot study. Clin. Chim. Acta 218 (1993) 29-38